CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance |
| |
Authors: | Randall H. Friedline David S. Brown Hai Nguyen Hardy Kornfeld JinHee Lee Yi Zhang Mark Appleby Sandy D. Der Joonsoo Kang Cynthia A. Chambers |
| |
Affiliation: | 1.Department of Pathology, 2.Department of Medicine, Graduate Program in Immunology and Virology, University of Massachusetts Medical School, Worcester, MA 01655;3.Amgen, Inc., South San Francisco, CA 94080;4.Zymogenetics, Inc., Seattle, WA 98102;5.Department of Laboratory Medicine and Pathobiology, Program in Proteomics and Bioinformatics, University of Toronto, M5S 3G4 Toronto, Canada |
| |
Abstract: | Cytotoxic T lymphocyte antigen-4 (CTLA-4) plays a critical role in negatively regulating T cell responses and has also been implicated in the development and function of natural FOXP3+ regulatory T cells. CTLA-4–deficient mice develop fatal, early onset lymphoproliferative disease. However, chimeric mice containing both CTLA-4–deficient and –sufficient bone marrow (BM)–derived cells do not develop disease, indicating that CTLA-4 can act in trans to maintain T cell self-tolerance. Using genetically mixed blastocyst and BM chimaeras as well as in vivo T cell transfer systems, we demonstrate that in vivo regulation of Ctla4−/− T cells in trans by CTLA-4–sufficient T cells is a reversible process that requires the persistent presence of FOXP3+ regulatory T cells with a diverse TCR repertoire. Based on gene expression studies, the regulatory T cells do not appear to act directly on T cells, suggesting they may instead modulate the stimulatory activities of antigen-presenting cells. These results demonstrate that CTLA-4 is absolutely required for FOXP3+ regulatory T cell function in vivo. |
| |
Keywords: | |
|
|